IFNG and COVID-19: NK cell activation may also be impaired in COVID‐19 patients due to down‐regulation of CD107a and cytokines such as IFN‐γ and TNF‐α but increased expression of NKG2A/CD94 that inhibits NK cell cytotoxicity (Zheng et al., 2020).